Target intelligence / Profile preview

Sodium-dependent neutral amino acid transporter type 2 (SLC1A5 (also known as ASCT2))

Target
SLC1A5 (also known as ASCT2)
Molecular classification
Transporter, Solute carrier family, Membrane protein
01

Overview

Sodium-dependent neutral amino acid transporter type 2 (SLC1A5, also known as ASCT2) is a membrane-bound transporter protein belonging to the solute carrier family 1. It primarily facilitates the sodium-dependent transport of neutral amino acids, particularly glutamine, across the plasma membrane[1][2]. ASCT2 is bi-directional and selective, harmonizing intracellular and extracellular amino acid pools. It is notably overexpressed in various malignancies and proliferative cells, making it an attractive pharmacologic target for inhibiting tumor growth by depriving cells of glutamine[2][4]. Beyond its transport role, SLC1A5 also serves as a receptor for certain retroviruses. The transporter’s structure, expression, and regulatory mechanisms are under active investigation due to its therapeutic potential in oncology and other proliferative diseases[1][2].

Other names
ASCT2AAATSystem ASCNeutral amino acid transporter B(0)Solute carrier family 1 member 5Baboon M7 virus receptorRD114/simian type D retrovirus receptor
02

Mechanism of action

Inhibitors typically block the transporter’s ability to import neutral amino acids (notably L-glutamine), depriving cancer cells of nutrients and suppressing cell proliferation and survival[2].\nTargeting SLC1A5 can disrupt tumor metabolism, growth, and mTOR signaling.

03

Biological functions

Amino acid transport (primarily neutral amino acids, especially L-glutamine)Regulation of cellular amino acid poolNa+-dependent antiporter activityCell surface receptor for certain retrovirusesRegulation of growth and metabolism, notably in cancer and proliferative cells
04

Disease associations

Cancer (notably lung cancer and other malignancies, due to increased amino acid demand and overexpression in tumor cells)Inflammation (due to upregulation in inflammatory and proliferative cells)Other (may play roles in metabolic and infectious diseases through amino acid regulation and viral entry)
05

Safety considerations

SLC1A5 is expressed in multiple normal tissues such as lung, placenta, skeletal muscle, kidney, pancreas, and intestine[1][2], so systemic inhibition may lead to unwanted effects in normal cells.Potential effects on normal amino acid metabolism in non-cancerous tissues remain a therapeutic challenge[2].
06

Interacting drugs

No approved drugs directly targeting SLC1A5 are widely available yet, but multiple experimental inhibitors such as V-9302 and benzylserine have been developed and are in preclinical or early-stage clinical evaluation as anticancer agents[2].
07

Biomarkers

Overexpression of SLC1A5 (ASCT2) can serve as a biomarker for poor prognosis or glutamine dependency, especially in cancers[2].

Beyond the preview

Go deeper on Sodium-dependent neutral amino acid transporter type 2 (SLC1A5 (also known as ASCT2)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-dependent neutral amino acid transporter type 2 (SLC1A5 (also known as ASCT2)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call